SAN FRANCISCO, June 13, 2016 /PRNewswire/ -- Medizone
International, Inc. (OTCQB: MZEI) is pleased to announce that its unprecedented room disinfection technology, AsepticSure®, has
been granted patent protection by the European Union Patent and Trademark Office (EU) for its patent application Bio-Terrorism Counter Measures Using Ozone and Hydrogen Peroxide. The European Patent Office awarded patent number
252583B to this application, which provides a government counter measures response to a biological attack.
Medizone already has a significant number of applications granted for its disinfection technology for health care and sports
facility disinfection. To date, AsepticSure has demonstrated a greater than 6-log kill (>99.9999% kill) against all
bacterial and viral pathogens it has been tested against. This EU patent grant expands on the previously awarded bio-terrorism
patent protection as awarded in the United States and Canada.
With this EU patent, Medizone secures patent protection in the United Kingdom, Germany and France.
Recently, Acinetobacter baumannii, another highly infective pathogen of concern to certain US government interests as well as
the government of South Africa, has been defeated by AsepticSure. To date, our AsepticSure
technology has defeated every infective pathogen - viral or bacterial - that it has been tested against. Eliminating all
infective pathogens from a disinfected space elements the infective reservoir, thus rendering the treated space harmless and
safe.
This Press Release may contain certain forward looking statements that could involve substantial risks and uncertainties,
including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development,
production efficiencies, product demand, competitive products, competitive environment, successful testing and government
regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange
Commission.
For press information on Medizone International, please contact:
John Pentony, Investor and Media Relations
Medizone International, Inc.
T: 01 415 331-0202
E: j.pentony@medizoneint.com
For more information, visit:
http://www.medizoneint.com
Email: operations@medizoneint.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/asepticsure-receives-eu-patent-approval-for-its-bio-terrorism-counter-measures-application-300282826.html
SOURCE Medizone International, Inc.